Mullen Leaves TuSimple (TSP) After Investor Lawsuit

Go back to Mullen Leaves TuSimple (TSP) After Investor Lawsuit

TUSIMPLE INVESTORS: 10/31/22 Filing Deadline in Securities Fraud Class Action – Contact Lieff Cabraser for More Details

September 8, 2022 9:01 AM EDT

SAN FRANCISCO--(BUSINESS WIRE)-- National plaintiffs law firm Lieff Cabraser Heimann & Bernstein, LLP announces that class action litigation has been filed on behalf of investors who purchased the common stock of TuSimple Holdings, Inc. (TuSimple or the Company) (NASDAQ: TSP) issued in connection with its Initial Public Offering (IPO) conducted on or about April 15, 2021; and/or between April 15, 2021 and August 1, 2022, inclusive (the Class Period). Contact Lieff Cabraser attorneys immediately for more information about the action. The deadline to apply to be a lead plaintiff is October 31, 2022.

Class Period: April 15, 2021 August 1, 2022 and/or in April 2021... More

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Abbott, TuSimple, Humanigen, and Kohl’s and Encourages Investors to Contact the Firm

September 6, 2022 10:18 PM EDT

NEW YORK, Sept. 06, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Abbott Laboratories (NYSE: ABT), TuSimple Holdings, Inc. (NASDAQ: TSP), Humanigen, Inc. (NASDAQ: HGEN), and Kohls Corporation (NYSE: KSS). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.

Abbott Laboratories... More